Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia

Table 1

Comparison of main status between treatment and control groups ().

Variable	Treatment group ()	Control group ()
Age (years)
≤60	78	74	0.115	0.734
>60	89	91
Sex
Men	87	88	0.015	0.821
Women	80	77
AML
M1	3	4	0.306	0.989
M2	11	10
M4	39	40
M5	29	28
M6	6	5
ALL
L1	44	44	0.013	0.993
L2	26	25
L3	9	9
KPS
≥90	17	21	1.299	0.522
70–90	116	105
≤70	34	39

Notes: AML: acute myeloid leukemia, ALL: acute lymphocytic leukemia, and KPS: Karnofsky Performance Status.